EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudieOpen Access

Short-Acting Oral Nifedipine versus Intravenous Labetalol for the Control of Severe Hypertension in the Postpartum Period: A Retrospective Cohort Study

Whitney A Booker iD, Shai Bejerano, Anna Frappaolo, Eliza C Miller, Natalie A Bello

American Journal of Perinatology · 01.04.2025 · 42 (06) · 806-812

DOI: 10.1055/a-2422-9768 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift American Journal of Perinatology, erschienen am 01.04.2025. Verfasst von Whitney A Booker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Vagelos College of Physician and Surgeons, Columbia University, New Yor…. Hauptthemen laut MEDLINE: Nifedipine, Labetalol, Antihypertensive Agents, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to compare the effectiveness of oral short-acting (SA) nifedipine with intravenous (IV) labetalol for the treatment of postpartum (PP) severe hypertension. We conducted a retrospective cohort study of women who delivered at a tertiary care facility between January and December 2018, had not previously received antihypertensive medication, and required treatment for PP severe hypertension defined as systolic blood pressure (SBP) ≥ 160 mm Hg and/or diastolic blood pressure (DBP) ≥110 mm Hg. Exposure groups were defined by the receipt of either oral SA nifedipine or IV labetalol. The primary outcome was time (minutes) to BP control (SBP < 160 mm Hg and DBP

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NifedipineLabetalolAntihypertensive AgentsHypertensionHumansFemaleRetrospective StudiesAdultAdministration, OralAdministration, IntravenousPostpartum PeriodBlood PressurePregnancyTreatment Outcome

Substanzen

NifedipineLabetalolAntihypertensive Agents

Autor:innen und Institutionen

  • Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Vagelos College of Physician and Surgeons, Columbia University, New York, New York.
  • Division of Stroke and Cerebrovascular Disease, Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York.
  • Department of Cardiology, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, California.

ORCID-Profile: Whitney A Booker

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Booker, W. A., Bejerano, S., Frappaolo, A., Miller, E. C., & Bello, N. A. (2025). Short-Acting Oral Nifedipine versus Intravenous Labetalol for the Control of Severe Hypertension in the Postpartum Period: A Retrospective Cohort Study. American Journal of Perinatology, 42(06), 806-812. https://doi.org/10.1055/a-2422-9768

Vancouver

Booker WA, Bejerano S, Frappaolo A, Miller EC, Bello NA. Short-Acting Oral Nifedipine versus Intravenous Labetalol for the Control of Severe Hypertension in the Postpartum Period: A Retrospective Cohort Study. American Journal of Perinatology. 2025;42(06):806-812. doi:10.1055/a-2422-9768

BibTeX
@article{Booker2025,
  author = {Booker, Whitney A and Bejerano, Shai and Frappaolo, Anna and Miller, Eliza C and Bello, Natalie A},
  title = {Short-Acting Oral Nifedipine versus Intravenous Labetalol for the Control of Severe Hypertension in the Postpartum Period: A Retrospective Cohort Study},
  journal = {American Journal of Perinatology},
  year = {2025},
  volume = {42},
  number = {06},
  pages = {806--812},
  doi = {10.1055/a-2422-9768}
}
Kostenlos starten →